HOTEL INFO: Please call us to assist with your room reservation
Secrets Akumal Riviera Maya (adult only resort)
ALL-INCLUSIVE= accommodations, all meals and snacks, all drinks (alcoholic or non-alcoholic), all entertainment, all tips & gratuities. Junior Suite Tropical View $257.00 per person per night based on double occupancy. Junior Suite Ocean View $272 per person per night based on double occupancy. Preferred Club Junior Suite Ocean View $334 per person per night based on double occupancy. Single and triple occupancy rooms available as well.
Mandatory to stay at this resort if attending seminars
Speaker: Gregory Holmquist, Pharm.D., BCOP, Pain and Palliative Care Specialist
Dr. Holmquist is on the Board of Advisors of the American Society of Pain Educators. Over the past decade, he has been invited to present over 1,000 CME and CE lectures on pain management across the country. He shares practical and relevant clinical information, with a touch of humor, ensuring that audiences not only listen but also hear an important message on managing pain and making a difference in the lives of their patients.
THE “A” TO “Z” OF MANAGING PAIN
Day 1: Know your Patient, Day 2: Know your Options: Opioids, Day 3: Know your Options: non-Opioids
1. Discuss the burden of opioid misuse and abuse on individuals and society.
2. Cite 3 common reasons certain patients are unable to obtain adequate pain control utilizing typical pain medications.
3. Differentiate addiction, physical dependency, tolerance and hyperalgesia.
4. Describe 3 non-pharmacological modalities that can assist with pain management.
5. Describe general management strategies for each of the following painful disease states / challenging patients: a. fibromyalgia, b. uncontrolled neuropathic pain, c. patient with hyperalgesia, d. end-of-life pain crisis, e. patient with a current or past history of addiction, f. non-communicative or elderly patient with dementia, g. chronic non-cancer pain patient on what appears to be excessively high dose of opioids.
6. Identify typical characteristics of patients who would be identified as “high risk”, “moderate risk”, and “low risk” for misusing, abusing, or diverting opioids.
7. Describe a “best practice model” for monitoring patients being prescribed opioids.
8. Demonstrate the ability to calculate a patient’s morphine milligram equivalence (MME).
9. Demonstrate how to calculate an equi-analgesic dose between different opioid products.
10. Be able to state similarities and differences between a variety of commercially available opioid products.
11. Compare and contrast the role and potential risks of using opioids, cannabinoids and gabapentenoids in a. acute postoperative pain, b. chronic low back pain, c. neuropathic pain, d. chronic non-cancer pain, and e. end-of-life pain crisis.
12. Describe the roles and risks of using acetaminophen, NSAIDs, antidepressants, anticonvulsants, topical lidocaine and other adjunctive medications in the management of pain.
13. Describe how a provider should counsel patients who are started on opioids, gabapentenoids and cannabinoids to minimize the risks of adverse reactions, over-dosage, and inappropriate compliance.
14. Compare and contrast the most common cannabinoids found in marijuana with regards to their benefits and risks in managing pain and other symptoms.
15. State the risks of combining opioids with: a. benzodiazepines, b. alcohol, c. gabapentenoids, and d. cannabinoids.
16. Describe the role of naloxone in preventing deaths from opioid overdosages.